Heru founder and CEO Mohamed Abou Shousha, MD, FRCS, PhD, discusses the origins behind re:Vive. The company launched the wearable visual field testing platform at Vision Expo West 2021 in Las Vegas, Nevada.
Mohamed Abou Shousha, MD, FRCS, PhD: My name is Mohamed Abou Shousha. I am the CEO and founder of Heru. I am also an associate professor at Bascom Palmer Eye Institute.
We are very proud to say that we are launching our first product here at Vision Expo West—re:Vive. We have been working on this for the last 10 years and we realized at Bascom Palmer that visual field testing is a bottleneck. So, it is done using medical grade furniture, it requires a room, a technician. And it is very difficult to do for the patient. And it is the most hated test in ophthalmology and optometry, I would say.
So, what we did is we launched this new app that actually is in a wearable device. We converted the test from being delivered by a 50 pound device to 13.7 ounce wearable device. And we also improved the accuracy by using active pupil tracking. So you know how it is when patients sit on a visual field tests and just keep clicking and looking everywhere. Now we have a pupil tracking that is tracking the eye of the patient, and only delivering the test when the patient is looking where they should be looking. That leads to better accuracy for the test.
We also have an automatic workflow. So we are able to provide the patient with a screening test that takes only 30 seconds. And when there is a visual field effect, it moves the patient automatically to a full threshold test.
Moreover, the test is smart, and it talks to you. So it is a gamified experience and a smart experience it talks to the patient tells the patient what to do. We also ran a clinical trial, comparing the accuracy of hero to the standard of care. And this is in process we have great news to share very soon.